Page last updated: 2024-08-18

isomethyleugenol and Benign Monoclonal Gammopathies

isomethyleugenol has been researched along with Benign Monoclonal Gammopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishida, T	1

Reviews

1 review(s) available for isomethyleugenol and Benign Monoclonal Gammopathies

Article	Year
[Chromosomal abnormalities and clonal evolution in multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10 Topics: B-Lymphocytes; Cell Differentiation; Chromosome Aberrations; Clonal Evolution; Epigenesis, Genetic; Gene Dosage; GTP Phosphohydrolases; Humans; Immunoglobulin Heavy Chains; MAP Kinase Signaling System; Membrane Proteins; Methylation; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Mutation; Plasma Cells; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); ras Proteins; Risk Factors	2014

Article

Year

[Chromosomal abnormalities and clonal evolution in multiple myeloma].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

Topics: B-Lymphocytes; Cell Differentiation; Chromosome Aberrations; Clonal Evolution; Epigenesis, Genetic; Gene Dosage; GTP Phosphohydrolases; Humans; Immunoglobulin Heavy Chains; MAP Kinase Signaling System; Membrane Proteins; Methylation; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Mutation; Plasma Cells; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); ras Proteins; Risk Factors

2014